Tri Locum Partners LP’s Axsome Therapeutics Inc. Position
Does Tri Locum Partners LP own Axsome Therapeutics Inc. (AXSM)? Yes — 62.1K shares worth $10M (+1.47% of its 13F portfolio) as of Q1 2026, down from 201.6K shares the prior filed quarter.
Position Value
$10M
Q1 2026
Shares
62.1K
% of Portfolio
+1.47%
Quarters Held
14
currently held
Position History AXSM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 62.1K | $10M | +1.47% |
| Q4 2025 | 201.6K | $37M | +4.78% |
| Q3 2025 | 292.1K | $35M | +8.16% |
| Q2 2025 | 157.9K | $16M | +5.00% |
| Q1 2025 | 101.2K | $12M | +6.06% |
| Q4 2024 | 249.8K | $21M | +4.38% |
| Q3 2024 | 91.7K | $8M | +1.97% |
| Q2 2024 | 306.5K | $25M | +6.24% |
| Q1 2024 | 102.7K | $8M | +2.84% |
| Q4 2023 | 130.7K | $10M | +4.76% |
| Q3 2023 | 142.5K | $10M | +3.18% |
| Q2 2023 | 200.1K | $14M | +5.34% |
| Q1 2023 | 149.2K | $9M | +2.80% |
| Q4 2022 | 200.1K | $15M | +6.24% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tri Locum Partners LP’s full portfolio or all institutional holders of AXSM.